Mechanisms of host defence against fungal infection

REFERENCES

• Adamson D.M., Cozad G.C. Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans. Journal of Bacteriology 1969; 100: 1271–1276
   PubMed Web of Science ®Google Scholar
• Ausiello C.M., Palma C., Spagnoli G.C., Piazza A., Casciani C.U., Cassone A. Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin-2 activated killer cells. Cellular Immunology 1989; 121: 349–359
   PubMed Web of Science ®Google Scholar
• Cassone A., Marconi P., Bistoni F., Mattia E., Sbaraglia G., Garaci E., Bonmassar E. Immunoadjuvant effects of Candida albicans and its cell wall fractions in a mouse lymphoma model. Cancer Immunology and Immunotherapy 1981; 10: 181–190
   Web of Science ®Google Scholar
• Cohen M.S., Isturiz R.E., Malech H.L., Root R.K., Wilfert C.M., Gutman L., Buckley H.R. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. American Journal of Medicine 1981; 71: 59–66
   PubMed Web of Science ®Google Scholar
• Diamond R.D. Cryptococcus neoformans. Principles and Practice of Infectious Diseases3rd edn., G.L. Mandell, R.G. Douglas, Jr, J.E. Bennett. Churchill Livingstone, New York 1990; 1980–1989, In
   Google Scholar
• Diamond R.D., Allison A.C. Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans. Infection and Immunity 1976; 14: 716–720
   PubMed Web of Science ®Google Scholar
• Diamond R.D., Huber E., Haudenschild C.C. Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes. Journal of Infectious Diseases 1983; 147: 474–483
   PubMed Web of Science ®Google Scholar
• Diamond R.D., Krzesicki R., Epstein B., Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in Aspergillus and mucormycosis. American Journal of Pathology 1978; 91: 313–328
   PubMed Web of Science ®Google Scholar
• Diamond R.D., Root R.K., Bennett J.E. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. Journal of Infectious Diseases 1972; 125: 367–376
   PubMed Web of Science ®Google Scholar
• Domer J., Elkins K., Ennist D., Baker P. Modulation of immune responses by surface polysaccharides of Candida albicans. Reviews of Infectious Diseases 1988; 10(2)S419–S422
   PubMedGoogle Scholar
• Flesch I.E.A., Schwamberger G., Kaufmann S.H.E. Fungicidal activity of IFN-gamma-activated macrophages: Extracellular killing of Cryptococcus neoformans. Journal of Immunology 1989; 142: 3219–3224
   PubMed Web of Science ®Google Scholar
• Ford S., Friedman L. Experimental study of the pathogenicity of aspergilli for mice. Journal of Bacteriology 1967; 94: 928–933
   PubMed Web of Science ®Google Scholar
• Fung P.Y.S., Murphy J.W. In vitro interactions of immune lymphocytes and Cryptococcus neoformans. Infection and Immunity 1982; 36: 1128–1138
   PubMed Web of Science ®Google Scholar
• Gerson S.L., Talbot G.H., Hurwitz S., Strom B.L., Lusk E.J., Cassileth P.A. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Annals of Internal Medicine 1984; 100: 345–351
   PubMed Web of Science ®Google Scholar
• Granger D.L., Perfect J.R., Durack D.T. Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity. Journal of Immunology 1986; 136: 672–680
   PubMed Web of Science ®Google Scholar
• Hidore M.R., Murphy J.W. Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells. Infection and Immunity 1986; 51: 547–555
   PubMed Web of Science ®Google Scholar
• Hill J.O., Harmsen A.G. Intrapulmonary growth and dissemination of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T-cells. Journal of Experimental Medicine 1991; 173: 755–758
   PubMed Web of Science ®Google Scholar
• Horn R., Wong B., Kiehn T.E., Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Reviews of Infectious Diseases 1985; 7: 646–655
   PubMedGoogle Scholar
• Howard D.H., Otto V. Experiments of lymphocyte-mediated cellular immunity in murine histoplasmosis. Infection and Immunity 1977; 16: 226–231
   PubMed Web of Science ®Google Scholar
• Huffnagle G.B., Yates J.L., Lipscomb M.F. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T-cells. Journal of Experimental Medicine 1991; 173: 793–800
   PubMed Web of Science ®Google Scholar
• Kan V.L., Bennett J.E. Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia. Journal of Infectious Diseases 1988; 158: 407–414
   PubMed Web of Science ®Google Scholar
• Khardori N., Chaudhary S., Mcconnachie P., Tewari R.P. Characterization of lymphocytes responsible for protective immunity to histoplasmosis in mice. Mykosen 1983; 26: 523–532
   PubMedGoogle Scholar
• Kothary M.H., Chase T., Jr., Macmillan J.D. Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infection and Immunity 1984; 43: 320–325
   PubMed Web of Science ®Google Scholar
• Kozel T.R., Wilson M.A., Farrell T.P., Levitz S.M. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infection and Immunity 1989; 57: 3412–3417
   PubMed Web of Science ®Google Scholar
• Lehrer R.I., Jan R.G. Interaction of Aspergillus fumigatus spores with human leukocytes and serum. Infection and Immunity 1970; 1: 345–350
   PubMedGoogle Scholar
• Levitz S.M. Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony stimulating factor to inhibit Cryptococcus neoformans. Infection and Immunity 1991; 59: 3393–3397
   PubMed Web of Science ®Google Scholar
• Levitz S.M., Diamond R.D. Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system. Infection and Immunity 1984; 43: 1100–1102
   PubMed Web of Science ®Google Scholar
• Levitz S.M., Diamond R.D. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. Journal of Infectious Diseases 1985; 152: 938–945
   PubMed Web of Science ®Google Scholar
• Levitz S.M., Diamond R.D. Mechanisms of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro. Journal of Infectious Diseases 1985; 152: 33–42
   PubMed Web of Science ®Google Scholar
• Levitz S.M., Dibenedetto D.J. Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infection and Immunity 1988; 56: 2544–2551
   PubMed Web of Science ®Google Scholar
• Levitz S.M., Farrell T.P. Human neutrophil degranulation stimulated by Aspergillus fumigatus. Journal of Leukocyte Biology 1990; 47: 170–175
   PubMed Web of Science ®Google Scholar
• Levitz S.M., Farrell T.P. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: Role of the capsule, opsonins, the culture surface, and cytokines. Infection and Immunity 1990; 58: 1201–1209
   PubMed Web of Science ®Google Scholar
• Levitz S.M., Farrell T.P., Maziarz R.T. Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture. Journal of Infectious Diseases 1991; 163: 1108–1113
   PubMed Web of Science ®Google Scholar
• Levitz S.M., Selsted M.E., Ganz T., Lehrer R.I., Diamond R.D. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. Journal of Infectious Diseases 1986; 154: 483–489
   PubMed Web of Science ®Google Scholar
• Lim T.S., Murphy J.W. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infection and Immunity 1980; 30: 5–11
   PubMed Web of Science ®Google Scholar
• Lipscomb M.F., Alvarellos T., Toews G.B., Tompkins R., Evans Z., Koo G., Kumar V. Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. American Journal of Pathology 1987; 128: 354–361
   PubMed Web of Science ®Google Scholar
• Luzzati A.L., Giacomini E., Torosantucci A., Giordani L., Cassone A. A mannoprotein constituent of Candida albicans cooperates with antigen in the induction of a specific primary antibody response in cultures of human lymphocytes. Journal of Biological Regulators and Homeostatic Agents 1990; 4: 142–149
   PubMed Web of Science ®Google Scholar
• Martin S.M., Jönsson A.G. An extracellular protease from Aspergillus fumigatus. Canadian Journal of Biochemistry 1965; 43: 1745–1753
   PubMedGoogle Scholar
• Merkow L.P., Epstein S.M., Sidransky H., Verney E., Pardo M. The pathogenesis of experimental pulmonary aspergillosis. American Journal of Pathology 1971; 62: 57–74
   PubMed Web of Science ®Google Scholar
• Miller G.P.G., Puck J. In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normal and infected subjects. Journal of Immunology 1984; 133: 166–172
   PubMed Web of Science ®Google Scholar
• Miller M.F., Mitchell T.G., Storkus W.J., Dawson J.R. Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody. Infection and Immunity 1990; 58: 639–645
   PubMed Web of Science ®Google Scholar
• Mody C.H., Lipscomb M.F., Street N.E., Toews G.B. Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. Journal of Immunology 1990; 144: 1472–1477
   PubMed Web of Science ®Google Scholar
• Monga D.P. Role of macrophages in resistance of mice to experimental cryptococcosis. Infection and Immunity 1981; 32: 975–978
   PubMed Web of Science ®Google Scholar
• Mullbacher A., Eichner R.D. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proceedings of the National Academy of Sciences, USA 1984; 81: 3835–3837
   PubMed Web of Science ®Google Scholar
• Murphy J.W., Mcdaniel D.O. In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. Journal of Immunology 1982; 128: 1577–1583
   PubMed Web of Science ®Google Scholar
• Nordwig A., Jahn W.F. A collagenolytic enzyme from Aspergillus oryzae. Purification and properties. European Journal of Biochemistry 1968; 3: 519–529
   PubMedGoogle Scholar
• Odds F.C. Candida infections: overview. CRC Critical Reviews in Microbiology 1987; 15: 1–5
   Google Scholar
• Quinti I., Palma C., Guerra E.C., Gomez M.J., Mezzaroma I., Aiuti F., Cassone A. Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Clinical and Experimental Immunology 1991; 85: 485–492
   PubMed Web of Science ®Google Scholar
• Rex J.H., Bennett J.E., Gallin J.I., Malech H.L., Decarlo E.S., Melnick D.A. In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. Journal of Infectious Diseases 1990; 163: 849–852
   Web of Science ®Google Scholar
• Rex J.H., Bennett J.E., Gallin J.I., Malech H.L., Melnick D.A. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. Journal of Infectious Diseases 1990; 162: 523–528
   PubMed Web of Science ®Google Scholar
• Rhodes J.C., Amlung T.W., Miller M.S. Isolation and characterization of an elastinolytic proteinase from Aspergillus flavus. Infection and Immunity 1990; 58: 2529–2534
   PubMed Web of Science ®Google Scholar
• Rhodes J.C., Bode R.B., Mccuan-Kirsch C.M. Elastase production in clinical isolates of Aspergillus. Diagnostic Microbiology and Infectious Disease 1988; 10: 165–170
   PubMed Web of Science ®Google Scholar
• Richard J.L., Thurston J.R. Effect of aflatoxin on phagocytosis of Aspergillus fumigatus spores by rabbit alveolar macrophages. Applied Microbiology 1975; 30: 44–47
   PubMedGoogle Scholar
• Robertson M.D., Kerr K.M., Seaton A. Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum components. Journal of Medical and Veterinary Mycology 1989; 27: 295–302
   PubMed Web of Science ®Google Scholar
• Scaringi L., Cornacchione P., Rosati E., Boccanera M., Cassone A., Bistoni F., Marconi P. Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans. Cellular Immunology 1990; 129: 271–287
   PubMed Web of Science ®Google Scholar
• Schaffner A., Douglas H., Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Journal of Clinical Investigation 1982; 69: 617–631
   PubMed Web of Science ®Google Scholar
• Schaffner A., Douglas H., Braude A.I., Davis C.E. Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infection and Immunity 1983; 42: 1109–1115
   PubMed Web of Science ®Google Scholar
• Tewari R.P., Sharma D.K., Mathur A. Significance of thymus-derived lymphocytes in immunity elicited by immunization with ribosomes or live yeast cells of Histoplasma capsulatum. Journal of Infectious Diseases 1978; 138: 605–613
   PubMed Web of Science ®Google Scholar
• Tewari R.P., Sharma D., Solotorovsky M., Lafemina R., Balint J. Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum. Infection and Immunity 1977; 15: 789–795
   PubMed Web of Science ®Google Scholar
• Torosantucci A., Boccanera M., Casalinuovo I., Pellegrini G., Cassone A. Differences in the antigenic expression of immunomodulatory mannoprotein constituents on yeast and mycelial forms of Candida albicans. Journal of General Microbiology 1990; 136: 1421–1428
   PubMedGoogle Scholar
• Torosantucci A., Palma C., Boccanera M., Ausiello C.M., Spagnoli G.C., Cassone A. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans. Journal of General Microbiology 1990; 136: 2155–2163
   PubMedGoogle Scholar
• Vecchiarelli A., Puliti M., Torosantucci A., Cassone A., Bistoni F. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cellular Immunology 1991; 134: 65–76
   PubMed Web of Science ®Google Scholar
• Waldorf A.R., Diamond R.D. Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzae spores and Aspergillus fumigatus conidia. Infection and Immunity 1985; 48: 458–463
   PubMed Web of Science ®Google Scholar
• Waldorf A.R., Levitz S.M., Diamond R.D. In vivo, bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. Journal of Infectious Diseases 1984; 150: 752–760
   PubMed Web of Science ®Google Scholar
• Washburn R.G., Dehart D.J., Agwu D.E., Bryant-Varela B.J., Julian N.C. Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography. Infection and Immunity 1990; 58: 3508–3515
   PubMed Web of Science ®Google Scholar
• Washburn R.G., Gallin J.I., Bennett J.E. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and myeloperoxidase-independent pathways. Infection and Immunity 1987; 55: 2088–2092
   PubMed Web of Science ®Google Scholar
• Washburn R.G., Hammer C.H., Bennett J.E. Inhibition of complement by culture supernatants of Aspergillus fumigatus. Journal of Infectious Diseases 1986; 154: 944–951
   PubMed Web of Science ®Google Scholar
• Weinberg P.B., Becker S., Granger D.L., Koren H.S. Growth inhibition of Cryptococcus neoformans by human alveolar macrophages. American Review of Respiratory Disease 1987; 136: 1242–1247
   PubMed Web of Science ®Google Scholar
• Whiteside T.L., Herberman R.B. Characteristics of natural killer cells and lymphokine-activated killer cells. Their role in the biology and treatment of human cancer. Immunology and Allergy Clinics of North America 1990; 10: 663–704
   Web of Science ®Google Scholar
• Williams D.M., Graybill J.R., Drutz D.J. Histoplasma capsulatum infection in nude mice. Infection and Immunity 1978; 21: 973–977
   PubMed Web of Science ®Google Scholar